Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Study 329 continuation phase: Safety and efficacy of paroxetine and imipramine in extended treatment of adolescent major depression.

Le Noury J, Nardo JM, Healy D, Jureidini J, Raven M, Tufanaru C, Abi-Jaoude E.

Int J Risk Saf Med. 2016 Sep 17;28(3):143-61. doi: 10.3233/JRS-160728.

2.

Authors' reply to Sasich and Linden.

Le Noury J, Nardo JM, Healy D, Jureidini J, Raven M, Tufanaru C, Abi-Jaoude E.

BMJ. 2015 Oct 14;351:h5412. doi: 10.1136/bmj.h5412. No abstract available.

PMID:
26467813
3.

Restoring Study 329: efficacy and harms of paroxetine and imipramine in treatment of major depression in adolescence.

Le Noury J, Nardo JM, Healy D, Jureidini J, Raven M, Tufanaru C, Abi-Jaoude E.

BMJ. 2015 Sep 16;351:h4320. doi: 10.1136/bmj.h4320.

4.

Impossible to draw meaningful conclusions from study of changes in antidepressant use after FDA warnings.

Nardo JM.

BMJ. 2014 Oct 9;349:g5643. doi: 10.1136/bmj.g5643. No abstract available.

PMID:
25301791
5.

Inadequacy of remote desktop interface for independent reanalysis of data from drug trials.

Jureidini JN, Nardo JM.

BMJ. 2014 Jul 9;349:g4353. doi: 10.1136/bmj.g4353. No abstract available.

PMID:
25008913
6.

ICD-11 should not repeat the mistakes made by DSM-5.

Frances AJ, Nardo JM.

Br J Psychiatry. 2013 Jul;203(1):1-2. doi: 10.1192/bjp.bp.113.127647.

PMID:
23818530

Supplemental Content

Loading ...
Support Center